Source:http://linkedlifedata.com/resource/pubmed/id/20852327
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
49
|
pubmed:dateCreated |
2010-11-29
|
pubmed:abstractText |
Lipids circulate in the blood in association with plasma lipoproteins and enter the tissues either after hydrolysis or as non-hydrolyzable lipid esters. We studied cardiac lipids, lipoprotein lipid uptake, and gene expression in heart-specific lipoprotein lipase (LpL) knock-out (hLpL0), CD36 knock-out (Cd36(-/-)), and double knock-out (hLpL0/Cd36(-/-)-DKO) mice. Loss of either LpL or CD36 led to a significant reduction in heart total fatty acyl-CoA (control, 99.5 ± 3.8; hLpL0, 36.2 ± 3.5; Cd36(-/-), 57.7 ± 5.5 nmol/g, p < 0.05) and an additive effect was observed in the DKO (20.2 ± 1.4 nmol/g, p < 0.05). Myocardial VLDL-triglyceride (TG) uptake was reduced in the hLpL0 (31 ± 6%) and Cd36(-/-) (47 ± 4%) mice with an additive reduction in the DKO (64 ± 5%) compared with control. However, LpL but not CD36 deficiency decreased VLDL-cholesteryl ester uptake. Endogenously labeled mouse chylomicrons were produced by tamoxifen treatment of ?-actin-MerCreMer/LpL(flox/flox) mice. Induced loss of LpL increased TG levels >10-fold and reduced HDL by >50%. After injection of these labeled chylomicrons in the different mice, chylomicron TG uptake was reduced by ?70% and retinyl ester by ?50% in hLpL0 hearts. Loss of CD36 did not alter either chylomicron TG or retinyl ester uptake. LpL loss did not affect uptake of remnant lipoproteins from ApoE knock-out mice. Our data are consistent with two pathways for fatty acid uptake; a CD36 process for VLDL-derived fatty acid and a non-CD36 process for chylomicron-derived fatty acid uptake. In addition, our data show that lipolysis is involved in uptake of core lipids from TG-rich lipoproteins.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/,
http://linkedlifedata.com/resource/pubmed/grant/AA019413,
http://linkedlifedata.com/resource/pubmed/grant/DK079221,
http://linkedlifedata.com/resource/pubmed/grant/HL45095,
http://linkedlifedata.com/resource/pubmed/grant/HL73029,
http://linkedlifedata.com/resource/pubmed/grant/P01 HL057278,
http://linkedlifedata.com/resource/pubmed/grant/R01 DK033301-25,
http://linkedlifedata.com/resource/pubmed/grant/R01 HL045095-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD36,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, VLDL,
http://linkedlifedata.com/resource/pubmed/chemical/Chylomicrons,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoprotein Lipase,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, VLDL,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/very low density lipoprotein...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1083-351X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
3
|
pubmed:volume |
285
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37976-86
|
pubmed:dateRevised |
2011-3-30
|
pubmed:meshHeading |
pubmed-meshheading:20852327-Animals,
pubmed-meshheading:20852327-Antigens, CD36,
pubmed-meshheading:20852327-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20852327-Cholesterol, VLDL,
pubmed-meshheading:20852327-Chylomicrons,
pubmed-meshheading:20852327-Fatty Acids,
pubmed-meshheading:20852327-Lipid Metabolism,
pubmed-meshheading:20852327-Lipoprotein Lipase,
pubmed-meshheading:20852327-Lipoproteins, VLDL,
pubmed-meshheading:20852327-Mice,
pubmed-meshheading:20852327-Mice, Knockout,
pubmed-meshheading:20852327-Myocardium,
pubmed-meshheading:20852327-Tamoxifen,
pubmed-meshheading:20852327-Triglycerides
|
pubmed:year |
2010
|
pubmed:articleTitle |
Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.
|
pubmed:affiliation |
Division of Preventive Medicine and Nutrition, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|